Biodesix announces new data on the veristrat® test to be presented at the 2025 asco annual meeting

Louisville, colo., may 22, 2025 (globe newswire) -- biodesix, inc. (nasdaq: bdsx), a leading diagnostic solutions company, announced today that new data will be presented at the 2025 american society of clinical oncology (asco) annual meeting in chicago, illinois at 2:30 pm et on saturday, may 31st.

BDSX Ratings Summary

BDSX Quant Ranking